Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0269 Transporter Info | ||||
Gene Name | SLC30A1 | ||||
Transporter Name | Zinc transporter 1 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Colon cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A1 in colon adenocarcinoma | [ 1 ] | |||
Location |
5'UTR (cg22855020) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.21E+00 | Statistic Test | p-value: 6.95E-07; Z-score: 1.59E+00 | ||
Methylation in Case |
7.64E-01 (Median) | Methylation in Control | 6.34E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC30A1 in colon adenocarcinoma | [ 1 ] | |||
Location |
5'UTR (cg08900781) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 2.39E-03; Z-score: -1.45E+00 | ||
Methylation in Case |
8.53E-01 (Median) | Methylation in Control | 8.79E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC30A1 in colon adenocarcinoma | [ 1 ] | |||
Location |
TSS1500 (cg15523238) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.50E+00 | Statistic Test | p-value: 3.15E-05; Z-score: 1.61E+00 | ||
Methylation in Case |
5.19E-01 (Median) | Methylation in Control | 3.45E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC30A1 in colon adenocarcinoma | [ 1 ] | |||
Location |
Body (cg07519873) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.67E+00 | Statistic Test | p-value: 3.26E-04; Z-score: 2.51E+00 | ||
Methylation in Case |
3.87E-01 (Median) | Methylation in Control | 2.32E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC30A1 in colon adenocarcinoma | [ 1 ] | |||
Location |
Body (cg21212995) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.19E+00 | Statistic Test | p-value: 1.55E-03; Z-score: 1.81E+00 | ||
Methylation in Case |
3.46E-01 (Median) | Methylation in Control | 2.91E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC30A1 in colon adenocarcinoma | [ 1 ] | |||
Location |
Body (cg11760099) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 2.20E-03; Z-score: 5.20E-01 | ||
Methylation in Case |
8.42E-01 (Median) | Methylation in Control | 8.03E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A1 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg24598094) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.32E+00 | Statistic Test | p-value: 4.17E-04; Z-score: -2.79E+00 | ||
Methylation in Case |
4.38E-01 (Median) | Methylation in Control | 5.77E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC30A1 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg01575408) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.25E+00 | Statistic Test | p-value: 1.24E-03; Z-score: -2.80E+00 | ||
Methylation in Case |
4.55E-02 (Median) | Methylation in Control | 5.68E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC30A1 in bladder cancer | [ 2 ] | |||
Location |
1stExon (cg19652869) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 4.27E-03; Z-score: -1.49E+00 | ||
Methylation in Case |
6.23E-02 (Median) | Methylation in Control | 6.97E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC30A1 in bladder cancer | [ 2 ] | |||
Location |
1stExon (cg24162367) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.39E+00 | Statistic Test | p-value: 2.88E-02; Z-score: -1.11E+00 | ||
Methylation in Case |
2.29E-02 (Median) | Methylation in Control | 3.19E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC30A1 in bladder cancer | [ 2 ] | |||
Location |
Body (cg12405231) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 3.62E-05; Z-score: -4.61E+00 | ||
Methylation in Case |
8.17E-01 (Median) | Methylation in Control | 8.88E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A1 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
TSS1500 (cg19267867) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 1.86E-03; Z-score: -4.08E-01 | ||
Methylation in Case |
2.97E-02 (Median) | Methylation in Control | 3.17E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC30A1 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
TSS1500 (cg25466974) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 9.96E-03; Z-score: -5.38E-01 | ||
Methylation in Case |
2.57E-02 (Median) | Methylation in Control | 2.80E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC30A1 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
TSS1500 (cg05152717) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.10E+00 | Statistic Test | p-value: 1.47E-02; Z-score: 4.73E-01 | ||
Methylation in Case |
2.73E-02 (Median) | Methylation in Control | 2.49E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC30A1 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
Body (cg01143423) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.24E+00 | Statistic Test | p-value: 2.85E-07; Z-score: 1.42E+00 | ||
Methylation in Case |
2.20E-02 (Median) | Methylation in Control | 1.77E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC30A1 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
Body (cg03763950) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.24E+00 | Statistic Test | p-value: 1.03E-04; Z-score: 7.39E-01 | ||
Methylation in Case |
2.11E-02 (Median) | Methylation in Control | 1.71E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC30A1 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
Body (cg04976746) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 1.65E-02; Z-score: 5.97E-01 | ||
Methylation in Case |
2.64E-02 (Median) | Methylation in Control | 2.49E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A1 in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg05152717) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.14E+00 | Statistic Test | p-value: 2.14E-02; Z-score: 8.14E-01 | ||
Methylation in Case |
1.04E-01 (Median) | Methylation in Control | 9.17E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC30A1 in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg13976045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.10E+00 | Statistic Test | p-value: 4.92E-02; Z-score: 4.93E-01 | ||
Methylation in Case |
3.47E-02 (Median) | Methylation in Control | 3.15E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC30A1 in colorectal cancer | [ 4 ] | |||
Location |
1stExon (cg24162367) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 1.95E-02; Z-score: -6.97E-01 | ||
Methylation in Case |
2.17E-02 (Median) | Methylation in Control | 2.43E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC30A1 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg04976746) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.25E+00 | Statistic Test | p-value: 7.68E-03; Z-score: -7.99E-01 | ||
Methylation in Case |
2.47E-02 (Median) | Methylation in Control | 3.09E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC30A1 in colorectal cancer | [ 4 ] | |||
Location |
Body (cg01143423) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 3.29E-02; Z-score: 5.74E-01 | ||
Methylation in Case |
9.60E-02 (Median) | Methylation in Control | 8.64E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A1 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg24598094) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.67E+00 | Statistic Test | p-value: 2.85E-09; Z-score: -1.61E+00 | ||
Methylation in Case |
3.18E-01 (Median) | Methylation in Control | 5.30E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC30A1 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg03763950) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.13E+00 | Statistic Test | p-value: 1.42E-04; Z-score: -5.82E-01 | ||
Methylation in Case |
5.91E-02 (Median) | Methylation in Control | 6.70E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A1 in HIV infection | [ 6 ] | |||
Location |
TSS1500 (cg13976045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.12E+00 | Statistic Test | p-value: 4.80E-02; Z-score: 4.71E-01 | ||
Methylation in Case |
4.55E-02 (Median) | Methylation in Control | 4.07E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC30A1 in HIV infection | [ 6 ] | |||
Location |
Body (cg03763950) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.17E+00 | Statistic Test | p-value: 4.11E-03; Z-score: -5.90E-01 | ||
Methylation in Case |
8.72E-02 (Median) | Methylation in Control | 1.02E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC30A1 in HIV infection | [ 6 ] | |||
Location |
Body (cg12405231) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 4.34E-03; Z-score: -6.57E-01 | ||
Methylation in Case |
9.34E-01 (Median) | Methylation in Control | 9.50E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A1 in papillary thyroid cancer | [ 7 ] | |||
Location |
TSS1500 (cg13976045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 1.76E-02; Z-score: 2.44E-01 | ||
Methylation in Case |
9.53E-02 (Median) | Methylation in Control | 9.22E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC30A1 in papillary thyroid cancer | [ 7 ] | |||
Location |
TSS1500 (cg24598094) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.16E+00 | Statistic Test | p-value: 4.93E-02; Z-score: -6.37E-01 | ||
Methylation in Case |
3.36E-01 (Median) | Methylation in Control | 3.90E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC30A1 in papillary thyroid cancer | [ 7 ] | |||
Location |
Body (cg03763950) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 3.83E-02; Z-score: -2.24E-01 | ||
Methylation in Case |
6.82E-02 (Median) | Methylation in Control | 7.05E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A1 in systemic lupus erythematosus | [ 8 ] | |||
Location |
TSS1500 (cg05152717) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 2.32E-02; Z-score: -4.67E-02 | ||
Methylation in Case |
9.35E-02 (Median) | Methylation in Control | 9.45E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Atypical teratoid rhabdoid tumor |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A1 in atypical teratoid rhabdoid tumor | [ 9 ] | |||
Location |
1stExon (cg19652869) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.60E+00 | Statistic Test | p-value: 1.64E-17; Z-score: -2.23E+00 | ||
Methylation in Case |
4.51E-01 (Median) | Methylation in Control | 7.21E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC30A1 in atypical teratoid rhabdoid tumor | [ 9 ] | |||
Location |
1stExon (cg24162367) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.73E+00 | Statistic Test | p-value: 1.24E-16; Z-score: -2.33E+00 | ||
Methylation in Case |
3.34E-01 (Median) | Methylation in Control | 5.76E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC30A1 in atypical teratoid rhabdoid tumor | [ 9 ] | |||
Location |
Body (cg01143423) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 4.77E-05; Z-score: 7.61E-01 | ||
Methylation in Case |
9.14E-01 (Median) | Methylation in Control | 8.39E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC30A1 in atypical teratoid rhabdoid tumor | [ 9 ] | |||
Location |
Body (cg03763950) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 4.28E-04; Z-score: 9.73E-01 | ||
Methylation in Case |
8.81E-01 (Median) | Methylation in Control | 8.18E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC30A1 in atypical teratoid rhabdoid tumor | [ 9 ] | |||
Location |
Body (cg04976746) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 1.09E-03; Z-score: -6.63E-01 | ||
Methylation in Case |
7.33E-01 (Median) | Methylation in Control | 8.00E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC30A1 in atypical teratoid rhabdoid tumor | [ 9 ] | |||
Location |
Body (cg08629942) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 7.68E-03; Z-score: -6.50E-01 | ||
Methylation in Case |
6.59E-01 (Median) | Methylation in Control | 7.24E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC30A1 in atypical teratoid rhabdoid tumor | [ 9 ] | |||
Location |
Body (cg12405231) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.29E+00 | Statistic Test | p-value: 2.73E-02; Z-score: -3.13E-01 | ||
Methylation in Case |
1.69E-01 (Median) | Methylation in Control | 2.19E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A1 in breast cancer | [ 10 ] | |||
Location |
Body (cg12405231) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 4.31E-02; Z-score: -4.51E-02 | ||
Methylation in Case |
8.89E-01 (Median) | Methylation in Control | 8.90E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A1 in pancretic ductal adenocarcinoma | [ 11 ] | |||
Location |
Body (cg11273176) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 2.00E-02; Z-score: -4.60E-01 | ||
Methylation in Case |
5.71E-01 (Median) | Methylation in Control | 6.05E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC30A1 in panic disorder | [ 12 ] | |||
Location |
Body (cg08629942) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 9.21E-01 | Statistic Test | p-value: 9.56E-06; Z-score: 8.58E-01 | ||
Methylation in Case |
-2.89E+00 (Median) | Methylation in Control | -3.14E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC30A1 in panic disorder | [ 12 ] | |||
Location |
Body (cg12405231) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.74E+00 | Statistic Test | p-value: 1.55E-02; Z-score: -5.35E-01 | ||
Methylation in Case |
1.34E-01 (Median) | Methylation in Control | 3.68E-01 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
Unclear Phenotype |
46 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
let-7b directly targets SLC30A1 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Proteomics | ||
miRNA Stemloop ID |
let-7b | miRNA Mature ID | let-7b-5p | ||
miRNA Sequence |
UGAGGUAGUAGGUUGUGUGGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human cervical cancer cell line (Hela) | ||||
Epigenetic Phenomenon 2 |
miR-106a directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-106a | miRNA Mature ID | miR-106a-5p | ||
miRNA Sequence |
AAAAGUGCUUACAGUGCAGGUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 3 |
miR-106b directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-106b | miRNA Mature ID | miR-106b-5p | ||
miRNA Sequence |
UAAAGUGCUGACAGUGCAGAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 4 |
miR-1277 directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1277 | miRNA Mature ID | miR-1277-5p | ||
miRNA Sequence |
AAAUAUAUAUAUAUAUGUACGUAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 5 |
miR-155 directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-155 | miRNA Mature ID | miR-155-5p | ||
miRNA Sequence |
UUAAUGCUAAUCGUGAUAGGGGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 6 |
miR-16 directly targets SLC30A1 | [ 13 ] | |||
Epigenetic Type |
microRNA | Experiment Method | Proteomics | ||
miRNA Stemloop ID |
miR-16 | miRNA Mature ID | miR-16-5p | ||
miRNA Sequence |
UAGCAGCACGUAAAUAUUGGCG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human cervical cancer cell line (Hela) | ||||
Epigenetic Phenomenon 7 |
miR-17 directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-17 | miRNA Mature ID | miR-17-5p | ||
miRNA Sequence |
CAAAGUGCUUACAGUGCAGGUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 8 |
miR-186 directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-186 | miRNA Mature ID | miR-186-5p | ||
miRNA Sequence |
CAAAGAAUUCUCCUUUUGGGCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 9 |
miR-187 directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-187 | miRNA Mature ID | miR-187-5p | ||
miRNA Sequence |
GGCUACAACACAGGACCCGGGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 10 |
miR-193b directly targets SLC30A1 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-193b | miRNA Mature ID | miR-193b-3p | ||
miRNA Sequence |
AACUGGCCCUCAAAGUCCCGCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 11 |
miR-20a directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-20a | miRNA Mature ID | miR-20a-5p | ||
miRNA Sequence |
UAAAGUGCUUAUAGUGCAGGUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 12 |
miR-20b directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-20b | miRNA Mature ID | miR-20b-5p | ||
miRNA Sequence |
CAAAGUGCUCAUAGUGCAGGUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 13 |
miR-3133 directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3133 | miRNA Mature ID | miR-3133 | ||
miRNA Sequence |
UAAAGAACUCUUAAAACCCAAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 14 |
miR-3191 directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3191 | miRNA Mature ID | miR-3191-5p | ||
miRNA Sequence |
CUCUCUGGCCGUCUACCUUCCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 15 |
miR-33a directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-33a | miRNA Mature ID | miR-33a-5p | ||
miRNA Sequence |
GUGCAUUGUAGUUGCAUUGCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 16 |
miR-33b directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-33b | miRNA Mature ID | miR-33b-5p | ||
miRNA Sequence |
GUGCAUUGCUGUUGCAUUGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 17 |
miR-3611 directly targets SLC30A1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3611 | miRNA Mature ID | miR-3611 | ||
miRNA Sequence |
UUGUGAAGAAAGAAAUUCUUA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 18 |
miR-4501 directly targets SLC30A1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4501 | miRNA Mature ID | miR-4501 | ||
miRNA Sequence |
UAUGUGACCUCGGAUGAAUCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 19 |
miR-4506 directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4506 | miRNA Mature ID | miR-4506 | ||
miRNA Sequence |
AAAUGGGUGGUCUGAGGCAA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 20 |
miR-4524b directly targets SLC30A1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4524b | miRNA Mature ID | miR-4524b-3p | ||
miRNA Sequence |
GAGACAGGUUCAUGCUGCUA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 21 |
miR-496 directly targets SLC30A1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-496 | miRNA Mature ID | miR-496 | ||
miRNA Sequence |
UGAGUAUUACAUGGCCAAUCUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 22 |
miR-497 directly targets SLC30A1 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-497 | miRNA Mature ID | miR-497-3p | ||
miRNA Sequence |
CAAACCACACUGUGGUGUUAGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 23 |
miR-511 directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-511 | miRNA Mature ID | miR-511-5p | ||
miRNA Sequence |
GUGUCUUUUGCUCUGCAGUCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 24 |
miR-519a directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-519a | miRNA Mature ID | miR-519a-3p | ||
miRNA Sequence |
AAAGUGCAUCCUUUUAGAGUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 25 |
miR-519b directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-519b | miRNA Mature ID | miR-519b-3p | ||
miRNA Sequence |
AAAGUGCAUCCUUUUAGAGGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 26 |
miR-519c directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-519c | miRNA Mature ID | miR-519c-3p | ||
miRNA Sequence |
AAAGUGCAUCUUUUUAGAGGAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 27 |
miR-519d directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-519d | miRNA Mature ID | miR-519d-3p | ||
miRNA Sequence |
CAAAGUGCCUCCCUUUAGAGUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 28 |
miR-526b directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-526b | miRNA Mature ID | miR-526b-3p | ||
miRNA Sequence |
GAAAGUGCUUCCUUUUAGAGGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 29 |
miR-548aa directly targets SLC30A1 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-548aa | miRNA Mature ID | miR-548aa | ||
miRNA Sequence |
AAAAACCACAAUUACUUUUGCACCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 30 |
miR-548ac directly targets SLC30A1 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-548ac | miRNA Mature ID | miR-548ac | ||
miRNA Sequence |
CAAAAACCGGCAAUUACUUUUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 31 |
miR-548ap directly targets SLC30A1 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-548ap | miRNA Mature ID | miR-548ap-3p | ||
miRNA Sequence |
AAAAACCACAAUUACUUUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 32 |
miR-548bb directly targets SLC30A1 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-548bb | miRNA Mature ID | miR-548bb-3p | ||
miRNA Sequence |
CAAAAACCAUAGUUACUUUUGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 33 |
miR-548d directly targets SLC30A1 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-548d | miRNA Mature ID | miR-548d-3p | ||
miRNA Sequence |
CAAAAACCACAGUUUCUUUUGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 34 |
miR-548h directly targets SLC30A1 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-548h | miRNA Mature ID | miR-548h-3p | ||
miRNA Sequence |
CAAAAACCGCAAUUACUUUUGCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 35 |
miR-548t directly targets SLC30A1 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-548t | miRNA Mature ID | miR-548t-3p | ||
miRNA Sequence |
AAAAACCACAAUUACUUUUGCACCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 36 |
miR-548z directly targets SLC30A1 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-548z | miRNA Mature ID | miR-548z | ||
miRNA Sequence |
CAAAAACCGCAAUUACUUUUGCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 37 |
miR-5571 directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-5571 | miRNA Mature ID | miR-5571-5p | ||
miRNA Sequence |
CAAUUCUCAAAGGAGCCUCCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 38 |
miR-5692a directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-5692a | miRNA Mature ID | miR-5692a | ||
miRNA Sequence |
CAAAUAAUACCACAGUGGGUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 39 |
miR-615 directly targets SLC30A1 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-615 | miRNA Mature ID | miR-615-3p | ||
miRNA Sequence |
UCCGAGCCUGGGUCUCCCUCUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 40 |
miR-6728 directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6728 | miRNA Mature ID | miR-6728-3p | ||
miRNA Sequence |
UCUCUGCUCUGCUCUCCCCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 41 |
miR-6744 directly targets SLC30A1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6744 | miRNA Mature ID | miR-6744-5p | ||
miRNA Sequence |
UGGAUGACAGUGGAGGCCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 42 |
miR-6776 directly targets SLC30A1 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6776 | miRNA Mature ID | miR-6776-3p | ||
miRNA Sequence |
CAACCACCACUGUCUCUCCCCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 43 |
miR-6830 directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6830 | miRNA Mature ID | miR-6830-3p | ||
miRNA Sequence |
UGUCUUUCUUCUCUCCCUUGCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 44 |
miR-7705 directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-7705 | miRNA Mature ID | miR-7705 | ||
miRNA Sequence |
AAUAGCUCAGAAUGUCAGUUCUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 45 |
miR-888 directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-888 | miRNA Mature ID | miR-888-5p | ||
miRNA Sequence |
UACUCAAAAAGCUGUCAGUCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 46 |
miR-93 directly targets SLC30A1 | [ 14 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-93 | miRNA Mature ID | miR-93-5p | ||
miRNA Sequence |
CAAAGUGCUGUUCGUGCAGGUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.